Ligand Pharmaceuticals Inc (LGND)

Operating Cash Flow Growth

138.13%

TTM · Period ending:

LGND logo

LGND Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported138.13%
LGND TTM Cash from Operations YoY % (-2.10% → 138.13%)
High-resolution chart · PNG

LGND operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
138.13%
133.7582%
-49.266%
-57.9093%
18.2073%
58.2182%
99.4859%
-20.354%
-56.6277%
-72.1414%
-64.724%
-15.208%
-3.3427%
-0.2232%
74.941%
116.7025%
151.1787%
147.9553%
44.3557%
10.668%
59.9431%
183.9541%
286.0717%
341.7021%
-36.6808%
-132.2991%
-115.1171%
-94.515%
-77.3206%
37.2378%
107.3989%
131.5852%
160.8669%
75.5617%
48.5183%
49.5357%
55.7652%
56.8046%
50.9838%
45.33%
50.5632%
84.8482%
102.8931%
71.3698%
73.0887%
20.6664%
-0.5993%
106.4463%
77.6783%
712.4617%
12,750.9317%
116.3004%
111.4174%
206.3622%
113.7372%
152.7558%
130.1776%
76.1479%
95.67%
64.9283%
47.5702%
59.7746%
19.9225%
-2.8003%
-8.0806%
27.6997%
-63.8836%
26.0806%
21.8808%
42.7829%
78.8953%
79.4201%
80.5202%
62.3049%
29.4497%
-308.2327%
-2,369.5796%
-1,716.5152%
-1,755.9594%
-274.1668%
-172.0107%
-233.2054%
45.3771%
285.6064%
220.9163%
5.7455%
2,000%
28.997%
55.1731%
118.4486%
101.0911%
2.9283%
13.6831%
-402.7951%
-26.1529%
25.6557%
34.3787%
85.1932%
57.9643%
47.1439%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.